According to LifeStance Health Group's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.05912. At the end of 2023 the company had a P/S ratio of 2.81.
Year | P/S ratio | Change |
---|---|---|
2023 | 2.81 | 29.95% |
2022 | 2.16 | -59.5% |
2021 | 5.34 |